Edmund J. D. Lee

发表

Tailoring of recommendations to reduce serious cutaneous adverse drug reactions: a pharmacogenomics approach.

E. Ren, Di Dong, C. Sung, 2017, Pharmacogenomics.

Pharmacogenetic profiling across the irinotecan pathway in Asian patients with cancer.

Y. Cheung, E. Tan, A. Sparreboom, 2005, British journal of clinical pharmacology.

Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients

E. Tan, B. Chowbay, O. Singh, 2013, European Journal of Clinical Pharmacology.

CYP3A5*3 and *6 single nucleotide polymorphisms in three distinct Asian populations

Y. Cheung, Q. Zhou, Edmund J. D. Lee, 2003, European Journal of Clinical Pharmacology.

Pharmacogenetics of Target Genes Across the Warfarin Pharmacological Pathway

W. Lim, B. Chowbay, X. Xiang, 2006, Clinical pharmacokinetics.

Population genetics of the angiotensin-converting enzyme in Chinese

Edmund J. D. Lee, 2006 .

Influence of Multiple Dose Activated Charcoal on the Disposition Kinetics of Irinotecan in Rats

Y. Cheung, Edmund J. D. Lee, C. Balram, 2002, Drug metabolism and drug interactions.

Influence of SLCO1B3 haplotype-tag SNPs on docetaxel disposition in Chinese nasopharyngeal cancer patients.

E. Tan, W. Lim, B. Chowbay, 2012, British journal of clinical pharmacology.

NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore.

M. Teh, W. Poh, W. Poh, 1999, Carcinogenesis.

The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging

Edmund J. D. Lee, D. Toh, J. Poh, 2013 .

Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients

P. Ang, B. Chowbay, E. Sandanaraj, 2008, Cancer science.

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients.

Y. Cheung, B. Chowbay, Q. Zhou, 2003, Pharmacogenetics.

Mutation screening in KCNQ1, HERG, KCNE1, KCNE2 and SCN5A genes in a long QT syndrome family.

C. Ching, S. Chan, S. Koo, 2007, Annals of the Academy of Medicine, Singapore.

Genes in a Long QT Syndrome Family

S. Chan, S. Koo, Edmund J. D. Lee, 2007 .

Takotsubo cardiomyopathy complicated by Dressler's syndrome

R. Hendriks, Edmund J. D. Lee, A. Whelan, 2008, The Medical journal of Australia.

Thiopurine S‐methyltransferase activity in a Chinese population

W. Kalow, Edmund J. D. Lee, 1993, Clinical pharmacology and therapeutics.

Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients

E. Tan, B. Chowbay, O. Singh, 2014, European Journal of Clinical Pharmacology.

The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients

E. Tan, W. Lim, B. Chowbay, 2011, Cancer Chemotherapy and Pharmacology.

CBR1 and CBR3 pharmacogenetics and their influence on doxorubicin disposition in Asian breast cancer patients

P. Ang, B. Chowbay, N. Wong, 2008, Cancer science.

Meta-analysis of the influence of MDR1 C3435T polymorphism on digoxin pharmacokinetics and MDR1 gene expression.

Y. Cheung, B. Chowbay, Huihua Li, 2005, British journal of clinical pharmacology.

The Importance of Ethnicity Definitions and Pharmacogenomics in Ethnobridging and Pharmacovigilance

W. Tan-Koi, Michael Limenta, Edmund J. D. Lee, 2019, Pharmacogenomics.

An Interethnic Comparison of Polymorphisms of the Genes Encoding Drug-Metabolizing Enzymes and Drug Transporters: Experience in Singapore

Shufeng Zhou, B. Chowbay, Edmund J. D. Lee, 2005, Drug metabolism reviews.

The modulation of irinotecan-induced diarrhoea and pharmacokinetics by three different classes of pharmacologic agents.

Y. Cheung, Amarnath Sharma, B. Chowbay, 2003, Oncology reports.

Novel SLC22A16 polymorphisms and influence on doxorubicin pharmacokinetics in Asian breast cancer patients.

Balram Chowbay, P. Ang, B. Chowbay, 2007, Pharmacogenomics.

Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients.

Y. Yap, B. Chowbay, N. Wong, 2011, British journal of clinical pharmacology.

PXR Pharmacogenetics: Association of Haplotypes with Hepatic CYP3A4 and ABCB1 Messenger RNA Expression and Doxorubicin Clearance in Asian Breast Cancer Patients

P. Ang, B. Chowbay, N. Wong, 2008, Clinical Cancer Research.

Preparative resolution of praziquantel enantiomers by simulated counter-current chromatography

C. Ching, S. Ng, Edmund J. D. Lee, 1993 .

Correlation between acetylation phenotype and genotype in Chinese women

A. Seow, Bin Zhao, Edmund J. D. Lee, 2000, European Journal of Clinical Pharmacology.

Dietary isothiocyanates, glutathione S-transferase -M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore.

M. Teh, W. Poh, Mimi C. Yu, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

A SIMPLEPHARMACOKINETICMETHOD FORSEPARATINGTHE THREE ACETYLATIONPHENOTYPES:A PRELIMINARYREPORT

H. Lee, Edmund J. D. Lee, 1982 .

Impact of CYP2D6, CYP3A5, CYP2C9 and CYP2C19 polymorphisms on tamoxifen pharmacokinetics in Asian breast cancer patients.

Y. Yap, B. Chowbay, N. Wong, 2011, British journal of clinical pharmacology.

Clinical Pharmacokinetics of Ciprofloxacin

Edmund J. D. Lee, K. Williams, 1990 .

Frequency of human CYP2D6 mutant alleles in a normal Chinese population

Edmund J. D. Lee, 2006 .